Table 2.
Site | Crude incidence rate per 100,000 | Age-standardized incidence rate per 100,000a) | ||||
---|---|---|---|---|---|---|
Both | Male | Female | Both | Male | Female | |
All sites | 551.6 | 541.9 | 561.3 | 347.6 | 361.1 | 353.1 |
Lip, oral cavity, and pharynx | 6.2 | 9.2 | 3.3 | 4.0 | 6.1 | 2.1 |
Esophagus | 4.6 | 8.5 | 0.8 | 2.7 | 5.5 | 0.4 |
Stomach | 68.9 | 94.1 | 43.8 | 41.3 | 61.3 | 24.3 |
Colon and rectum | 74.8 | 92.4 | 57.2 | 44.7 | 60.7 | 31.0 |
Liver | 34.0 | 50.1 | 17.9 | 20.4 | 32.6 | 9.5 |
Gallbladderb) | 11.9 | 11.9 | 11.8 | 6.5 | 7.8 | 5.5 |
Pancreas | 12.4 | 13.3 | 11.5 | 7.0 | 8.7 | 5.6 |
Larynx | 2.1 | 4.0 | 0.1 | 1.2 | 2.6 | 0.1 |
Lung | 50.4 | 69.5 | 31.3 | 28.2 | 44.7 | 15.8 |
Breast | 38.4 | 0.3 | 76.5 | 25.4 | 0.2 | 50.5 |
Cervix uteri | 6.1 | - | 12.2 | 4.0 | - | 7.8 |
Corpus uteri | 4.8 | - | 9.5 | 3.1 | - | 6.2 |
Ovary | 4.7 | - | 9.3 | 3.2 | - | 6.2 |
Prostate | 29.2 | 58.3 | - | 16.9 | 38.1 | - |
Testis | 0.5 | 1.0 | - | 0.5 | 1.0 | - |
Kidney | 10.2 | 14.2 | 6.3 | 6.5 | 9.5 | 3.9 |
Bladder | 8.3 | 13.5 | 3.2 | 4.6 | 8.7 | 1.5 |
Brain and CNS | 3.7 | 4.0 | 3.4 | 3.0 | 3.4 | 2.6 |
Thyroid | 129.4 | 44.6 | 214.2 | 90.4 | 31.2 | 150.4 |
Hodgkin lymphoma | 0.6 | 0.8 | 0.4 | 0.5 | 0.7 | 0.4 |
Non-Hodgkin lymphoma | 10.5 | 11.5 | 9.4 | 7.2 | 8.4 | 6.2 |
Multiple myeloma | 2.9 | 3.2 | 2.7 | 1.7 | 2.1 | 1.5 |
Leukemia | 6.2 | 7.0 | 5.4 | 5.3 | 6.2 | 4.4 |
Other and ill-defined | 30.7 | 30.6 | 30.9 | 19.4 | 21.7 | 17.4 |
CNS, central nervous system.
Age adjusted to the world standard population,
Includes the gallbladder and other/unspecified parts of the biliary tract.